Medicale Corp. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Medicale Corp. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q3 2020 to Q3 2024.
  • Medicale Corp. Deferred Tax Assets, Valuation Allowance for the quarter ending September 30, 2024 was $36.9K, a 49.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $36.9K +$12.2K +49.5% Sep 30, 2024 10-K 2025-01-14
Q3 2023 $24.7K +$7.8K +46.2% Sep 30, 2023 10-K 2025-01-14
Q3 2022 $16.9K +$8.3K +96.5% Sep 30, 2022 10-K 2024-01-02
Q3 2021 $8.6K +$8.2K +2023% Sep 30, 2021 10-K 2022-12-02
Q3 2020 $405 Sep 30, 2020 10-K 2021-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.